Cover Image

Enhancing Outcomes in Opioid Use Disorder Treatment: An Economic Evaluation of Improving Medication Adherence for Buprenorphine Through Blister-Packaging

Eric P Borrelli,1 Peter Saad,2 Nathan E Barnes,2 Heather Nelkin,3 Doina Dumitru,3 Julia D Lucaci4 1Health Economics & Outcomes Research; Becton, Dickinson and Company, San Diego, CA, USA; 2Medical Affairs; Becton, Dickinson and Company, Durham, NC, USA; 3Medical Affairs; Becton, Dickinson and Co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Borrelli EP (Author), Saad P (Author), Barnes NE (Author), Nelkin H (Author), Dumitru D (Author), Lucaci JD (Author)
Format:	Book
Published:	Dove Medical Press, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving Adherence and Reducing Health Care Costs Through Blister-Packaging: An Economic Model for a Commercially Insured Health Plan
by: Borrelli EP, et al.
Published: (2024)

Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
by: Celine M. Laffont, et al.
Published: (2022)

Advances in the delivery of buprenorphine for opioid dependence
by: Rosenthal RN, et al.
Published: (2017)

Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder
by: Ronquest NA, et al.
Published: (2018)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017)

Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
by: Ling W, et al.
Published: (2019)

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
by: Anna Beth Parlier-Ahmad, et al.
Published: (2021)

Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum]
by: Ling W, et al.
Published: (2020)

A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
by: James C. Miller, et al.
Published: (2023)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
by: Hiroko Furo, et al.
Published: (2021)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
by: Rena Eudy‐Byrne, et al.
Published: (2021)

Association of Receipt of Opioid Prescription for Acute Post-Delivery Pain Management with Buprenorphine Discontinuation among Postpartum People with Opioid Use Disorder
by: Taylor N. Hallet, et al.
Published: (2024)

Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
by: Benjamin R Brady, et al.
Published: (2021)

Comment on "A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes"
by: Robert G. Newman M.D., M.P.H, et al.
Published: (2013)

Comment on "A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes"
by: Robert G. Newman, et al.
Published: (2013)

Mouse Models for Blistering Skin Disorders
by: Radhika Ganeshan, et al.
Published: (2010)

Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section
by: Alane B O'Connor, et al.
Published: (2022)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
by: Phillips-Jackson H, et al.
Published: (2020)

Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder
by: Ruihua Dong, et al.
Published: (2019)

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
by: Lori Regenstreif, et al.
Published: (2022)

Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico
by: Darlene Santiago, et al.
Published: (2020)

Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
by: Laura G Duncan, et al.
Published: (2015)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
by: Webster LR, et al.
Published: (2016)

An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine
by: Leana J. Pande, et al.
Published: (2023)

Stability of levothyroxine tablets in blister packaging versus bottles and vials under simulated in-use conditions
by: Jonathan Chun
Published: (2022)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
by: Travis M. Scott, et al.
Published: (2017)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients-A Critical Review
by: Michael Soyka
Published: (2021)

Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder
by: Laura Szczesniak, et al.
Published: (2024)

Adherence to a flexible extended regimen for oral hormonal contraception provided in a blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studies
by: Elliesen J, et al.
Published: (2016)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
by: Soyka M
Published: (2015)

New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
by: Itzoe M, et al.
Published: (2017)

Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study
by: Björn Johnson, et al.
Published: (2022)

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced µ-Opioid Receptor Regulation
by: Géraldine Poisnel, et al.
Published: (2009)

Do buprenorphine doses and ratios matter in medication assisted treatment adherence?
by: Kevin Kavanagh, PharmD, BCPP, et al.
Published: (2023)

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization
by: Meng Gu, et al.
Published: (2023)

Simple but effective blister-forming trick in suction blister technique
by: Sandeep Mahapatra, et al.
Published: (2019)